Log In
BCIQ
Print this Print this
 

CardiAMP Therapy

  Manage Alerts
Collapse Summary General Information
Company BioCardia Inc.
DescriptionHigh-dose autologous bone marrow-derived cells delivered transendocardially
Molecular Target
Mechanism of Action 
Therapeutic ModalityCell therapy: Stem cell
Latest Stage of DevelopmentPhase III
Standard IndicationHeart failure
Indication DetailsTreat heart failure; Treat heart failure developed after a heart attack
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/24/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today